David Mason

David Mason has a diverse and extensive work experience in the healthcare industry. David most recently served as the Chief Medical Officer at MiMedx since December 2018. Prior to that, they held the position of Vice President, Medical Affairs-Clinical Programs at MiMedx Group, Inc. starting in June 2014. In addition, they had a brief role as a Business Owner at Percept Biosciences in April 2014. Previously, they spent several years at Given Imaging, where they held the position of Sr VP, Chief Medical Officer from December 2008 to March 2014. Prior to that, they served as Chief Medical Officer at Percept BioSciences from January 2008 to November 2008. David also has extensive experience at UCB, where they served as the Global Head of Inflammation Clinical Research from an unspecified time in 2003 to 2007. Additionally, they held the position of Sr VP Clinical and Regulatory Affairs at AVI BioPharma from 2000 to 2003. David began their career at Elan Pharmaceuticals, where they held the position of Vice President, Medical Affairs from an unspecified time in 1997 to 2000. Before that, they were the VP Medical Affairs and Chief Medical Officer at Elan from an unspecified time in 1994 to 2000. David's earliest recorded position was as the VP, Clinical Sciences at Lederle Laboratories from an unspecified time in 1990 to 1992. Throughout their career, David has held various high-level positions in medical affairs, clinical research, and regulatory affairs.

David Mason attended Williams College from 1965 to 1969, where they received a Bachelor of Arts degree in Chemistry. Following this, they attended Duke University School of Medicine from 1969 to 1973 and obtained a Medical Doctor (MD) degree in Medicine.